Stay updated on ARO-HIF2 in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page no longer displays a government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe two screenshots show the same study record for NCT04169711 with no changes to core content such as study design, eligibility criteria, or listed locations. The differences appear to be cosmetic/layout adjustments and update timestamps.SummaryDifference0.5%

- Check63 days agoChange DetectedThe page now includes newer dates and multiple specific research site references, and removes several older date stamps and a generic 'Last Update Posted' label.SummaryDifference2%

- Check71 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check78 days agoChange DetectedTerm naming updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.SummaryDifference0.4%

Stay in the know with updates to ARO-HIF2 in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.